Global Ophthalmology Drugs & Devices Market
Please click here to get the relevant report of Ophthalmology Drugs & Devices Market (Contact Lens, Optical Coherence Tomography (OCT) Scanner, IOL, Dry Eye, AMD, Glaucoma & Phacoemulsification) – Competitive Landscape & Global Forecasts To 2017
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
Lack of health insurance amongst population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about the ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst rural population about the various ophthalmic disorders such as cataract.
The ophthalmology drugs market is classified based on the type of drugs; treatment based drugs, over the counter drugs and ocular anesthetics. Ocular anesthetics are administered by surgeons during surgery and can not be bought by individuals. The treatment based drugs are provided based on the diagnosed conditions and are classified as dry eye drugs, retinal disorder drugs, anti-allergy/inflammatory/infective drugs and anti-glaucoma drugs. Over the counter drugs can be procured without any need of a prescription. This report analyses drugs and devices in the ophthalmology market along with its sub-segments for their revenues, key growth drivers and opportunities.
The Global Ophthalmology Drug and Devices Market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014.
Market estimates and forecast
The report provides in-depth market estimates and forecast for ophthalmology devices based on major eye disorders such as cataract, refractive error and other retinal disorders. It segments the global ophthalmology drugs market on the basis of treatment based drugs, OTC drugs and anesthetics.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
- We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
- 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
Powerful Research and Analysis
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
Global Ophthalmology Drugs & Devices Market to reach $36 billion by 2014
The Global Ophthalmology Drug and Devices Market report analyzes the ophthalmology drugs and devices market over the period 2009-2014. It studies the major market drivers and opportunities for the ophthalmology drugs and devices market and also evaluates the major trends in the macro- and micro-markets with respect to different geographic regions.
Global ophthalmology devices and drugs market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
Lack of health insurance amongst population especially within the developing countries or lack of insurance covering all types of IOLs or contact lens in developed countries is a significant challenge faced by the ophthalmology industry. The other challenges include low awareness about the ophthalmic disorders, especially in developing countries. This is primarily due to the lack of awareness amongst rural population about the various ophthalmic disorders such as cataract.
The ophthalmology drugs market is classified based on the type of drugs; treatment based drugs, over the counter drugs and ocular anesthetics. Ocular anesthetics are administered by surgeons during surgery and can not be bought by individuals. The treatment based drugs are provided based on the diagnosed conditions and are classified as dry eye drugs, retinal disorder drugs, anti-allergy/inflammatory/infective drugs and anti-glaucoma drugs. Over the counter drugs can be procured without any need of a prescription. This report analyses drugs and devices in the ophthalmology market along with its sub-segments for their revenues, key growth drivers and opportunities.
The global Ophthalmology Drug and Devices market is expected to reach a market size of $36 billion by the year 2014, at a CAGR of 5.4% from 2009-2014. The drugs market is expected to reach a size of $19.8 billion by the year 2014 growing at a CAGR of 4% from 2009-2014.
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of contents
1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points from Secondary Sources
1.5.4 Key Data Points from Primary Sources
1.5.5 Assumptions
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Evolution
3.3 Market Segmentation
3.4 Market Dynamics
3.5 Industry Benchmarking
3.6 End User Analysis
3.7 Market Share Analysis
4 Ophthalmology Devices Market
4.1 By Surgery
4.1.1 Cataract Surgery Devices
4.1.1.1 Intra Ocular Lens (IOL)
4.1.1.1.1 Monofocal
4.1.1.1.2 Multifocal
4.1.1.1.3 Toric
4.1.1.1.4 Accomodating
4.1.1.2 Ophthalmic Viscoelastic Devices (OVD)
4.1.1.2.1 Cohesive
4.1.1.2.2 Dispersive
4.1.1.3 Phacoemulsification devices
4.1.2 Glaucoma Surgery Devices
4.1.2.1 Glaucoma Drainage Devices
4.1.2.2 Glaucoma Lasers
4.1.2.3 Stents and Implants
4.1.2.4 Systems
4.1.3 Refractive Surgery Devices
4.1.4 Excimer Laser
4.1.5 Femtosecond Laser
4.1.6 YAG Laser
4.1.7 Microkeratome
4.1.8 Vitreo Retinal Surgery Devices
4.1.8.1 Vitrectomy Machines
4.1.8.2 Photocoagulation Lasers
4.1.9 Ophthalmic Lasers
4.1.9.1 Excimer Laser
4.1.9.2 Femtosecond Laser
4.1.9.3 YAG Laser
4.1.9.4 Glaucoma Lasers
4.1.9.5 Photocoagulation Lasers
4.2 Ophthalmic Diagnostic & Monitoring Equipment
4.2.1 Optical Coherence Tomographers (OCT Scanners)
4.2.2 Fundus cameras
4.2.2.1 Non-Mydriatic
4.2.2.2 Mydriatic
4.2.2.3 Non-Mydriatic / Mydriatic
4.2.3 Slit lamps
4.2.4 Visual Field Analyzers/Perimeters
4.2.5 Wavefront aberrometers
4.2.6 Ophthalmic Ultrasound Imaging Systems
4.2.7 Ophthalmoscopes
4.2.8 Tonometers
4.2.9 Autorefractors/Phoropters
4.2.10 Keratometers
4.2.11 Corneal topographers
4.2.12 Retinoscope
4.2.13 Pachymeter
4.2.14 Specular Microscope
4.2.15 Biometers
4.2.16 Optotype projectors
4.2.17 Dioptometers
4.3 Vision care
4.3.1 Contact lens
4.3.2 Spectacles
5 Ophthalmology drugs market
5.1 Treatment based ophthalmology drugs
5.1.1 Dry eye drugs
5.1.1.1 Existing
5.1.1.1.1 Restasis
5.1.1.1.2 Hyalein
5.1.1.1.3 Diquas
5.1.1.2 Pipeline
5.1.1.2.1 Cyclokat
5.1.1.2.2 Vekacia
5.1.1.2.3 SAR1118 - Lifitegrast
5.1.2 Retinal disorders
5.1.2.1 Existing
5.1.2.1.1 Lucentis
5.1.2.1.2 Visudyne
5.1.2.1.3 Avastin (Off-label)
5.1.2.1.4 Eylea
5.1.2.2 Pipeline
5.1.2.2.1 Ocriplasmin (Microplasmin)
5.1.2.2.2 Iluvien (fluocinolone acetonide intravitreal insert)
5.1.2.2.3 Betamethasone (DE-102)
5.1.3 Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs
5.1.3.1 Existing
5.1.3.1.1 Patanol / Pataday / Opatanol
5.1.3.1.2 Bepreve
5.1.3.1.3 TobraDex
5.1.3.1.4 Xibrom / Bromday
5.1.3.1.5 Vigamox / Moxeza
5.1.3.1.6 AzaSite
5.1.3.2 Pipeline
5.1.3.2.1 Prolensa (LC Bromday)
5.1.3.2.2 Sirolimus (DE-109)
5.1.4 Anti-glaucoma drugs market
5.1.4.1 Existing
5.1.4.1.1 Xalatan / Xalacom
5.1.4.1.2 Lumigan
5.1.4.1.3 Tapros / Saflutan / Taflotan
5.1.4.1.4 Alphagan P / Combigan
5.1.4.1.5 Cosopt / Trusopt
5.1.4.1.6 Azarga
5.1.4.1.7 Azopt
5.1.4.2 Pipeline
5.1.4.2.1 Brinzolamide / Brimonidine tartrate
5.1.4.2.2 DE-111 (Tafluprost / timolol maleate)
5.1.4.2.3 DE-118 (Tafluprost)
6 Drug delivery types
6.1 Capsules & Tablets
6.2 Gels
6.3 Eye drops
6.4 Eye ointment
6.5 Eye Solutions
7 Geographical Analysis
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 ROW
8 Company Profiles
8.1 Abbott Medical Optics, Inc.
8.2 Alcon Inc.
8.3 Allergan, Inc.
8.4 Bausch & Lomb Inc.
8.5 Carl-Zeiss AG
8.6 Ellex Medical Lasers Ltd.
8.7 Essilor International S.A.
8.8 Hoya Corporation
8.9 Insight Vision Inc.
8.10 Iridex
8.11 Johnson & Johnson Vision Care, Inc.
8.12 Merck & Co., Inc
8.13 Nidek Co.Ltd
8.14 Novagali Pharma S A
8.15 Novartis International AG
8.16 Pfizer Inc
8.17 Roche Holding Ltd
8.18 Staar Surgicals
8.19 Topcon Corporation
8.20 Ziemer Ophthalmic Systems AG
Generating Response ...
Growth opportunities and latent adjacency in Global Ophthalmology Drugs & Devices Market